Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Wellspect ApS
APS
Active
CVR 42712744
Maglebjergvej 10, 2800
Kongens Lyngby
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2021 · 4 years old
3 employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Wellspect ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
3M
7M
10M
14M
5M
2022
12M
2023
9M
2024
10M
2025
EBITDA
DKK millions
9M
7M
4M
2M
0M
3M
2022
7M
+133%
2023
4M
-43%
2024
6M
+50%
2025
Income statement
DKK thousands
Item
2022
2023
2024
2025
Gross profit
5.045
11.951
9.419
9.812
Staff expenses
-2.482
-4.569
-5.005
-3.337
EBITDA
2.563
7.383
4.414
6.476
Depreciation & amort.
-1.572
-2.470
-2.921
-2.696
EBIT
991
4.913
1.493
3.780
Net financials
-151
-144
-412
-768
Profit before tax
840
4.768
1.081
3.012
Tax
-0
931
416
-164
Net profit
840
3.837
665
3.176
Balance sheet
DKK thousands
Item
2022
2023
2024
2025
Total assets
36.023
39.605
36.185
45.972
Equity
8.380
12.217
9.658
12.833
Long-term debt
0
0
0
0
Short-term debt
27.643
27.387
26.528
33.138
Total debt
27.643
27.387
26.528
33.138
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
66.0%
This company
2022
2025
Soliditetsgrad
27.9%
This company
38.2%
Market median
-27% vs market
2022
2025
Egenkapitalforrentning
24.7%
This company
18.4%
Market median
+34% vs market
2022
2025
Nettoresultatgrad (af bruttofortjeneste)
32.4%
This company
2022
2025
Aktivomsætning (af bruttofortjeneste)
0.21×
This company
2022
2025
Gæld/egenkapital
2.58×
This company
0.62×
Market median
-316% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-09-28 – 2022-12-31
View
PDF
More on Wellspect ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
